The agency started the review after finding a senior chemist manipulated data, impacting the accuracy of thousands of tests going back several years.

Investors already wanted to see what companies like Microsoft Corp. and its Big Tech peers plan to spend on artificial intelligence, and how those investments are working for the businesses so far ...